|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
T2 Biosystems, Inc.
| | | Phone: | (781) 457-1200 | Fax: | (781) 357-3080 | Year Established: | 2006 | Ticker: | TTOO | Exchange: | NASDAQ | Main Contact: | John McDonough, CEO | | Other Contacts: | David P. Harding, CCO Michael Gibbs, Esq., VP & General Counsel Alec Barclay, VP, Product Development & Program Management Rahul Dhanda, Senior VP, Corporate Development Michael A. Pfaller, M.D., CMO Darlene Deptula-Hicks, CFO Joanne Spadoro, Ph.D., COO Tom Lowery, Ph.D., CSO
| | Company Description | T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables the fast and sensitive detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, eliminating the time-consuming sample prep required in current methods. | |
|
|
|
|
|